Results 41 to 50 of about 16,189 (104)
Channel Dysfunction as the Basis for Comorbidities in Multiple Sclerosis and Depression
Archiv der Pharmazie, Volume 359, Issue 6, June 2026.Ion channel remodelling induced by neuroinflammation in multiple sclerosis alters neuronal excitability and immune signalling, creating shared molecular pathways that link multiple sclerosis pathology to depression and reveal novel pharmacological targets.
Nicole Rychlik +4 more
wiley +1 more source
A Solid-state NMR Study of Formoterol Fumarate [PDF]
, 2009 Spectra have been obtained for each of the three formoterol fumarate solvates diethanol, diisopropanol and dibenzyl alcohol and, with the aid of solution-state data and dipolar dephasing experiments, carbon-13 spectral assignments have been made.
Markwell, Andrew Fraser
core
Clinical Pharmacology &Therapeutics, Volume 119, Issue 6, Page 1565-1573, June 2026.There is a paucity of data regarding the effects of prenatal disease‐modifying therapies (DMTs) for multiple sclerosis (MS), on congenital anomalies in the offspring. Moreover, data on the association with neurodevelopmental disorders are lacking. This is an historical cohort study, within the Israeli Clalit Health Services database (2005–2024) that ...
Bar Rosh +4 more
wiley +1 more source
Pharmacoepidemiology and Drug Safety, Volume 35, Issue 4, April 2026.ABSTRACT Immunocompromised individuals experience an impaired immune function due to conditions that might be either congenital or acquired over the course of their lives. Epidemiological studies often rely on clinical definitions which, in some cases, benefit from being translated into machine‐readable algorithms for application to electronic health ...
Judit Riera‐Arnau +62 more
wiley +1 more source
, 2019 Supplemental material, MSJ-19-0334.R2_Supplemental_Figure_2 for Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study by Robert T Naismith, Jerry S ...
Mark S Freedman (5235176) +19 more
core +1 more source
Neurology and TherapyIntroduction Multiple sclerosis (MS) is a heterogeneous disease affecting a diverse population. Compared with white people with MS (PwMS), Black PwMS have more severe disease and higher incidence of MS, whereas Hispanic PwMS experience earlier onset ...
Sophia Woodson +12 more
doaj +1 more source
Annals of Clinical and Translational Neurology, Volume 12, Issue 11, Page 2214-2225, November 2025.ABSTRACT Objective Prognostication of disease course and prediction of treatment response in multiple sclerosis is an unmet need. We compared the performance of serum neurofilament light chain Z scores (age‐ and BMI‐adjusted) with absolute concentrations for the prediction of response to disease‐modifying therapy.
Maximilian Einsiedler +43 more
wiley +1 more source
European Journal of Neurology, Volume 32, Issue 11, November 2025.ABSTRACT Background Regenerative strategies in progressive multiple sclerosis (MS) pose a significant unmet need. Combining immunomodulatory treatment with remyelinating interventions to target the complex underlying pathogenesis appeals as the next frontier in MS therapeutic developments.
Anna‐Victoria De Keersmaecker +11 more
wiley +1 more source
From static difference to time-resolved spectroscopy of coupled electron and proton transfer in the quinol: fumarate reductase of Wolinella succinogenes [PDF]
, 2011 The enzyme quinol:fumarate reductase (QFR) from the anaerobic epsilon-proteobacterium Wolinella succinogenes is a membrane protein complex that couples the catalysis of the oxidation of menaquinol to menaquinone to that of the reduction of fumarate to ...
Paul, Rajsekhar, Paul, R.
core
, 2019 Supplemental material, MSJ-19-0334.R2_Supplemental_Figure_1 for Diroximel fumarate (DRF) in patients with relapsing–remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study by Robert T Naismith, Jerry S ...
Mark S Freedman (5235176) +19 more
core +1 more source